bicalutamide has been researched along with Eyelid Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukamizu, H; Ito, T; Sakamoto, K; Tanioka, F; Tokura, Y | 1 |
1 other study(ies) available for bicalutamide and Eyelid Neoplasms
| Article | Year |
|---|---|
Primary signet-ring cell/histiocytoid carcinoma of the eyelid expressing androgen receptors and treated with bicalutamide.
Topics: Aged; Androgen Antagonists; Anilides; Biomarkers, Tumor; Carcinoma, Signet Ring Cell; Eyelid Neoplasms; Humans; Male; Nitriles; Receptors, Androgen; Tosyl Compounds | 2017 |